SEP 21, 2019 6:51 PM PDT

Specialized neurons may hinder memories during dream sleep

WRITTEN BY: Nina Lichtenberg

Rapid eye movement (REM) sleep is a phase of sleep when dreams are created. Traditionally, REM has been thought of as a sleep stage important for memory consolidation, or the long-term storage of memories. Now, a team of Japanese and U.S. researchers show that (in their mouse model) it may also be a time when the brain forgets.

“Ever wonder why we forget many of our dreams?” said Dr. Thomas Kilduff, director of the Center for Neuroscience at SRI International in Menlo Park, CA, and a senior author of the study published in Science. “Our results suggest that the firing of a particular group of neurons during REM sleep controls whether the brain remembers new information after a good night’s sleep.”

REM is fascinating – it first occurs about 90 minutes after falling asleep and is characterized by darting eyes, paralyzed limbs, and dreaming. During REM, our brains are almost as active as when we are awake.

Learn about the stages of sleep below:

It has long been known that sleep is important for new memory storage. But scientists have wondered if sleep – in particular, REM – may also be important for erasing or forgetting excess information. Recent studies have demonstrated that during REM sleep the brain prunes or trims neural connections between cells involved in learning.

"Understanding the role of sleep in forgetting may help researchers better understand a wide range of memory-related diseases like post-traumatic stress disorder and Alzheimer's," said Dr. Janet He, program director at the National Institute of Neurological Disorders and Stroke (NINDS). "This study provides the most direct evidence that REM sleep may play a role in how the brain decides which memories to store."

In the study, Dr. Kilduff's lab and that of his collaborator, Dr. Akihiro Yamanaka, at Nagoya University in Japan examined specialized neurons in the hypothalamus, a brain region important for many of the body’s regulatory processes (i.e., hunger, sex, hormones). These neurons produce melanin concentrating hormone (MCH), a chemical needed for sleep and appetite. Researchers found that a majority (52.8%) of the MCH cells fired when mice experienced REM sleep, while only 35% fired when mice were awake. About 12% fired at both times.

Researchers then used genetic tools to turn the MCH neurons on and off during memory tests. Surprisingly, they found that “turning on” the neurons worsened memory retention, whereas “turning off” the cells improved memory. Additional experiments showed an exclusive role for MCH neurons in REM sleep – mice performed better on memory tests when the cells were turned off during REM, but not when they were awake or in another stage of sleep.

"These results suggest that MCH neurons help the brain actively forget new, possibly, unimportant information," said Kilduff. "Since dreams are thought to primarily occur during REM sleep, the sleep stage when the MCH cells turn on, activation of these cells may prevent the content of a dream from being stored in the hippocampus - consequently, the dream is quickly forgotten."

Source: EurekAlert!, SciTechDaily

About the Author
You May Also Like
JAN 03, 2020
Drug Discovery & Development
JAN 03, 2020
Researchers Grow Psilocybin from E. Coli Bacteria
Previously considered to be narcotic, and under tight regulation as an illicit drug for decades, research from recent years on the possible medicinal prope...
JAN 06, 2020
Cardiology
JAN 06, 2020
Online Therapy Treats Depression in Heart Disease Patients
People suffering from cardiovascular disease (CVD) often suffer from depression too- something that can lead to a vicious cycle in which CVD can be negativ...
JAN 14, 2020
Drug Discovery & Development
JAN 14, 2020
Promising Treatment for Dementia: Antibiotics
A class of antibiotics, known as the ‘aminoglycosides’ may serve as a promising treatment for frontotemporal dementia—according to resear...
JAN 17, 2020
Neuroscience
JAN 17, 2020
Fewer Connections Between Brain Cells for Schizophrenia
Approximately 1% of the world’s population have schizophrenia, with 3.2 million Americans having the disorder. Now, for the first time, advanced brai...
MAR 01, 2020
Genetics & Genomics
MAR 01, 2020
Treating Huntington's Disease With a Gene Therapy That Targets Brain Cells
A new therapeutic approach for Huntington's disease may aid patients with other neurodegenerative disorders....
MAR 01, 2020
Neuroscience
MAR 01, 2020
AI Robot Boosts Social Skills in Autistic Children
A team of researchers from the University of Southern California have developed a “socially assistive robot” called Kiwi that is capable of tea...
Loading Comments...